Tissue Regenix Group plc (AIM:TRX)

Tissue Regenix Group Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 27, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	24	43	37	40	38	38
Market Cap Growth	16.73%	16.73%	-7.68%	5.65%	-0.93%	227.82%
Enterprise Value	29	48	40	41	36	27
Last Close Price	0.34	0.60	0.52	0.56	0.54	0.54
Forward PE	-	250.00	-	-	-	-
PS Ratio	1.04	1.87	1.58	1.95	2.57	3.14
PB Ratio	1.03	1.84	1.59	1.57	1.52	1.35
P/TBV Ratio	2.13	3.81	2.75	2.72	2.53	2.15
P/FCF Ratio	-	-	74.38	-	-	-
P/OCF Ratio	-	-	44.85	-	-	-
EV/Sales Ratio	1.15	2.09	1.74	2.01	2.45	2.21
EV/EBITDA Ratio	26.43	46.40	113.67	-	-	-
EV/EBIT Ratio	100.48	171.24	-	-	-	-
EV/FCF Ratio	-7.32	-	81.76	-	-	-
Debt / Equity Ratio	0.36	0.36	0.32	0.32	0.24	0.19
Debt / EBITDA Ratio	7.50	7.50	16.11	-	-	-
Debt / FCF Ratio	-	-	14.98	-	-	-
Asset Turnover	0.65	0.65	0.66	0.53	0.41	0.36
Inventory Turnover	1.23	1.23	1.46	1.28	1.17	1.16
Quick Ratio	1.08	1.08	1.72	1.59	2.59	3.76
Current Ratio	3.46	3.46	4.03	3.32	5.06	6.16
Return on Equity (ROE)	-2.92%	-2.92%	-5.55%	-8.14%	-13.91%	-34.70%
Return on Assets (ROA)	0.49%	0.49%	-0.55%	-2.72%	-5.21%	-5.84%
Return on Capital (ROIC)	0.56%	0.56%	-0.63%	-3.09%	-5.79%	-6.54%
Return on Capital Employed (ROCE)	0.90%	0.90%	-	-	-	-
Earnings Yield	-2.39%	-1.33%	-3.67%	-5.64%	-9.43%	-24.10%
FCF Yield	-16.52%	-9.22%	1.34%	-3.50%	-8.90%	-14.74%
Buyback Yield / Dilution	-5.46%	-5.46%	-0.12%	-0.02%	-58.13%	-279.54%

Updated Sep 10, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.